Aberdeen Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Aberdeen Asset Management's GILD Position: Q2 2017 in Review
Aberdeen Asset Management increased its Gilead Sciences (GILD) stake by 9.3% in Q2 2017, buying an estimated $11.7M and bringing the position to 2,057,324 shares worth $146M. The position accounts for 0.49% of the portfolio, ranked #41.
Aberdeen Asset Management first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $191M in Q2 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.
- Aberdeen Asset Management held 2,057,324 shares of Gilead Sciences worth $146M as of Q2 2017.
- Aberdeen Asset Management bought 175,102 Gilead Sciences shares in Q2 2017, an estimated $11.7M.
- Gilead Sciences made up 0.49% of Aberdeen Asset Management's portfolio in Q2 2017, its #41 holding.
- Aberdeen Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
- Aberdeen Asset Management's Gilead Sciences position peaked at $191M in Q2 2015.
- 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.
Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.